D-0261-2024 Class I Ongoing
FDA drug recall D-0261-2024 was initiated by PFIZER on Dec 21, 2023 and is designated Class I. Reason for recall: Presence of particulate matter: glass The recall status is ongoing. Affected quantity: 3,546 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 31, 2024
- Initiation Date
- Dec 21, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,546 vials
Product description
Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18
Reason for recall
Presence of particulate matter: glass
Distribution pattern
Nationwide in the USA, Netherlands and Libya
Code information
Lot #: BL12206A, Exp date 06/30/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0261-2024
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for PFIZER? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.